Navigation Links
Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test
Date:4/30/2013

SAN DIEGO, April 30, 2013 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the US market launch of its proprietary new test, PROMETHEUS® Anser™ ADA.  This novel test measures drug (adalimumab) and drug antibody levels in one serum sample in inflammatory bowel disease (IBD) patients using adalimumab (ADA) – helping physicians identify potential causes for loss of treatment response and thus help guide patient management decisions. PROMETHEUS Anser ADA, which utilizes Prometheus' proprietary homogenous mobility shift assay, follows the July 2012 introduction of PROMETHEUS Anser IFX to further expand the line of tests that target biologic agents being used to treat a variety of autoimmune diseases.

The Crohn's and Colitis Foundation of America estimates that approximately 1.4 million Americans suffer from IBD.  Many of these patients will use a biologic treatment like adalimumab to manage and control the symptoms of their disease.  Over time, however, these biologic agents may lose their effectiveness, resulting in increased disease activity and high discontinuation rates. This loss of treatment response is typically the result of: (1) insufficient drug levels, or (2) the development of antibodies to the biologic agent itself.

Recent clinical studies suggest that as many as 44 percent of IBD patients who have lost response to adalimumab have antibodies to the drug.1 If a patient loses treatment response to ADA, the most common first step for physicians is dose escalation, however depending on the mechanism of the loss of response, this may result in exposure of the patient to unneeded high drug doses and unnecessary expense.

"PROMETHEUS Anser ADA marks the latest milestone in our ongoing commitment to developing diagnostics to help guide personalized treatment decisions for gastroenterologists, patients
'/>"/>

SOURCE Prometheus Laboratories Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
2. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
3. UBM Medica US Launches Practice Management iPad App, Offering Efficient Business Solutions for Busy Physicians
4. NextDocs Launches QuickStart for Emerging Growth Companies
5. Neusoft Medical Launches New Products to Global Market at 2013 Spring CMEF
6. Healthcares First Direct Contracting Market Launches Today; Will Offer Mutually Beneficial Approach for Hospitals and Suppliers
7. Sanovas Launches Next Generation Surgical Imaging Technology
8. MR Solutions Launches Complete Range of Pre Clinical Helium Free MRI Scanners
9. CSOS Launches the Guangdong-Hong Kong "999" Emergency Assistance Membership Programme
10. AsthmaSense Cloud Launches With New Features To Better Monitor Asthma
11. Aribex Launches NOMAD Pro 2 in US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- The U.S. Department of Health and Human Services (HHS) ... Case Medical Center Seidman Cancer Center totaling $4.7 million ... care for patients with complex cancer. ... unique model developed at UH to enhance care for ... demonstrated need for high health care utilization.  ...
(Date:7/10/2014)... , July 10, 2014  Breg, Inc., a ... has launched the FreeRunner™ knee brace with new ... from patella mal-tracking return to active lifestyles.  FreeRunner,s ... other braces, providing support when patients need it ... they don,t. Patellofemoral issues are the ...
(Date:7/10/2014)... 2014 Integrated Silicon Solution, Inc. (Nasdaq: ... analog IC solutions, today announced that it will host ... at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) ... 2014 third quarter ended June 30, 2014. ... before 6:50 a.m. Pacific time on July 24, 2014.  ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... Baxa Corporation, a leading,provider of systems for safe ... addition of two new international product,distributors. These agreements ... Pentafarma & Co. in The Dominican Republic -- ... expand product promotion in South,America and the Caribbean. ...
... Design ... and Test AIDS Vaccines, NEW YORK, Sept. ... from Executive Director,Mitchell Warren about the announcement that vaccinations have been,discontinued ... candidate developed by the Merck Research Laboratories: "Today,s announcement about ...
Cached Medicine Technology:Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 2AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result 2AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result 3
(Date:7/10/2014)... 2014 CBPartners, a global leader in ... a new website. The redesigned site boasts improved ... to the firm’s thought pieces, blog posts, and conference ... to showcase our insights, capabilities, and to provide timely ... Executive Officer, Cyrus Chowdhury. “An enhanced online presence ...
(Date:7/10/2014)... Port Washington, New York (PRWEB) July 10, 2014 ... law firm dedicated to protecting the rights of ... a couple has brought a lawsuit over allegations ... through her body by a power morcellator used ... lawsuit has been filed against Richard Wolf Medical ...
(Date:7/10/2014)... not nurture, may play the bigger role in the ... "As is the case in humans, genes matter ... William Hopkins of the Yerkes National Primate Research Center ... journal Current Biology . The findings might ... humans, Hopkins, team said. According to the researchers, ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July ... the hot flashes that often accompany menopause, new research suggests. ... percent of menopausal women, said Dr. Taraneh Shirazian, an assistant ... Icahn School of Medicine at Mount Sinai Hospital in New ... 10 hot flashes a day, and she added that hot ...
(Date:7/10/2014)... 2014In response to today,s announcement that the "Mississippi Baby," ... now been found to have detectable levels of the ... disappointment in this setback but remains hopeful that the ... remain undetectable for more than two years will continue ... ultimately develop a cure. , "Although we had ...
Breaking Medicine News(10 mins):Health News:CBPartners Announces New Website 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 3Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 4Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 5Health News:Like Humans, Chimps' Smarts May Rely on Genes 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS 2
... Serena Gordon HealthDay Reporter , SUNDAY, May 20 (HealthDay ... of adverse health problems, such as high blood pressure and heart ... cancer, the sleep disorder may raise their risk of dying from ... who have 30 or more episodes of low or no oxygen ...
... , MONDAY, May 21 (HealthDay News) -- Shortness of ... chronic obstructive pulmonary disease (COPD), a new, small study ... can inhibit healthy sex lives and is more common ... is a term used to describe certain lung conditions ...
... Spanish . Flexible sigmoidoscopy, a screening test ... side effects than colonoscopy, is effective in reducing the rates ... to research sponsored by the National Cancer Institute, part of ... spanned almost 20 years, researchers found that overall colorectal cancer ...
... the UK, have just launched a major new trial investigating ... heart failure (CHF)., Since home oxygen therapy (HOT) can be ... required to offer some clear guidance about whether HOT should ... 669,000 people in the UK aged over 45 have the ...
... From Finland to Italy and from Spain to Lithuania, thirteen ... three-year Hialine study. The coordinator was Professor Dr Jeroen Buters ... Allergy & Environment (ZAUM). The mission was to study the ... pollen (germ cells) of birch trees, grass and olive plants. ...
... NY, May 21, 2012Currently more than 10% of preschoolers ... target pregnancy, infancy, and toddlers are urgently needed to ... proposed in an article in Childhood Obesity , ... The article is available free online ahead of print ...
Cached Medicine News:Health News:Sleep Apnea Linked to Higher Cancer Death Risk 2Health News:Sleep Apnea Linked to Higher Cancer Death Risk 3Health News:COPD Can Put a Damper on Sex Life 2Health News:NIH study finds sigmoidoscopy reduces colorectal cancer rates 2Health News:NIH study finds sigmoidoscopy reduces colorectal cancer rates 3Health News:NIH study finds sigmoidoscopy reduces colorectal cancer rates 4Health News:Should oxygen be used for patients with chronic heart failure? 2Health News:Some pollens are much more aggressive than others 2Health News:A systems approach to preventing obesity in early life 2
Inquire...
Inquire...
... Before TOPscan Dispensers used to only have two ... process the completed job at a wholesale lab, ... The alternative was to finish the order in ... additional offices required another edger, lens inventory, more ...
Inquire...
Medicine Products: